メテナミン馬尿酸錠の世界市場 – 2030 年までの業界動向と予測

メテナミン馬尿酸錠の市場分析と規模

尿路感染症の発生率は世界的に増加しており、成人女性の50～60%に上ると報告されているため、メテナミン馬尿酸錠の需要は市場に大きな成長をもたらすと予想されています。さらに、API開発に対する政府の支援の拡大と製薬業界への投資の増加も市場の成長を拡大しています。

データブリッジ市場調査は、2023年から2030年の予測期間におけるメテナミン馬尿酸錠市場の成長率を分析しています。メテナミン馬尿酸錠市場の予想CAGRは、上記の予測期間中に約6.50％になる傾向があります。市場は2022年に89億米ドルと評価され、2030年までに147億3000万米ドルにまで成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

メテナミン馬尿酸錠市場の範囲とセグメンテーション

市場の定義

Methenamine hippurate tablets are the type of antiseptic drugs which is indicated for urinary tract infections. Methenamine hippurate tablets are manufactured by mixing some other compounds, including povidone, magnesium stearate, and saccharin sodium. This tablet has been reported to get readily absorbed by the gastrointestinal tract and thus effectively distributed in the body fluid. A single dose of methenamine hippurate tablets has been recorded to show antibacterial activity after half an hour of single 1g dose administration. From the overall tablet methenamine moiety excreted out with urine however the hippurate

Methenamine Hippurate Tablets Market Dynamics

Drivers

• Availability of Different Dosage Forms

The extensive availability of different dosage forms are enhancing the growth of the market. 20 Tablets/Bottle is a type of Hydroxycut, which contains a mixture of Amide and Carboxylic Acid salts. It is soluble in water and ethanol. Then there is another form called 60 Tablets/Bottle, a form of methenamine hippurate. It is used to treat horses having chronic diarrhea and is as an anti-carrhythmic drug in humans. It is a very effective anti-carrhythmic drug available today it contains approximately 1 mg of the active ingredient. Then , a bottle is a type of container with a neck that is narrower than the body. Bottles are often made of glass, plastic, and ceramic. Thus, all these different availability is boosting the growth of the market.

Opportunities

• Rising Cases of Urinary Tract Infections

Community-associated UTI (CAUTI) incidence is 0.7% and the primary risk factors are age, history of UTI, sexual activity and diabetes. Globally, around 150 million individuals develop UTIs. The highest incidence of symptomatic infections is prevalent in young, sexually active women aged 18 to 24 years, with one-third to one-half of women reported having at least one UTI by age 32. In the U.S., 70–80% of complicated UTIs are attributable to catheters, resulting in 1 million cases per year. Thus, this boosts the market growth.

 Restraints/Challenges

• Severe Effects of Methenamine Hippurate Tablets

The common symptoms associated with methenamine hippurate tablets are nausea, diarrhea, abdominal cramps, vomiting, and loss of appetite. If any of these effects continue or get worsen, immediate consultation is necessary. Painful or difficult urination may occur with methenamine, although less often.

This methenamine hippurate tablets market market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the methenamine hippurate tablets market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth

Global Methenamine Hippurate Tablets Market Scope

The methenamine hippurate tablets market is segmented on the basis of type, application, population type, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• 20 Tablets/Bottle
• 6 Tablets/ Bottle

Application

• Uncomplicated UTIs
• Healthcare-associated UTIs

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Methenamine Hippurate Tablets Market Regional Analysis/Insights

The methenamine hippurate tablets market is analyzed and market size insights and trends are provided by type, application, end user, distribution channel as referenced above.

The major countries covered in the methenamine hippurate tablets market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Europe has been witnessing the highest growth for the methenamine hippurate tablets market throughout the forecasted period because of the constant rise in the chronic infections among women and growing cases of postmenopausal UTIs.

North America dominates the market because of the growing disposable income and increasing cases of urological procedures. Furthermore, Europe accounts the second largest market share because of the rising awareness for urinary tract infections and wide presence of distribution network for methenamine hippurate tablets.

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更についても説明しています。また、国別データの予測分析を提供しながら、グローバルブランドの存在と入手可能性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されています。   

競争環境と世界のメテナミン馬尿酸錠市場シェア分析

メテナミン馬尿酸錠市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、メテナミン馬尿酸錠市場に関連する会社の焦点にのみ関連しています。

メテナミン馬尿酸錠市場で活動している主要企業は次のとおりです。

• バリダス・ファーマシューティカルズLLC（米国）
• アルボゲン（米国）
• Micro Labs USA, Inc. (インド)
• Aurobindo Pharma USA（米国）
• エデンブリッジ・ファーマシューティカルズ LLC (米国)
• クリエイティブオーガニック（インド）
• ビアトリス社（米国）
• コアファーマLLC（米国）

SKU-59068